Simulations Plus Inc.

Simulations Plus Inc.

SLP

Get informed when a big investor buys or sells

+ Follow
Market Cap$367.74M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Simulations Plus Inc.Simulations Plus Inc.-5.8--47%6.10.1
$18.50

Target Price by Analysts

0.6% upsideSimulations Plus Target Price DetailsTarget Price
$24.74

Current Fair Value

34.5% upside

Undervalued by 34.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$367.74 Million
Enterprise Value$348.72 Million
Dividend Yield$0.24 (-)
Earnings per Share$-3.22
Beta1.33
Outstanding Shares20,150,000

Return

Return on Equity-46.94%ROE
Return on Assets-42.86%
Return on Invested Capital-106.48%

Valuation & Multiples

P/E Ratio-5.83P/E Ratio
PEG-12.27PEG
Price to Sales6.13Price to Sales
Price to Book Ratio3.07Price to Book Ratio
Enterprise Value to Revenue4.33
Enterprise Value to EBIT-2.44
Enterprise Value to Net Income-6
Total Debt to Enterprise0.02
Debt to Equity0.05Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 9, 2026
EPS Estimate
$0.27
Average shareholder expectation
Revenue Estimate
$21.66 M
Average shareholder expectation

Next Earnings Call

Expected Date
July 9, 2026
EPS Estimate
$0.23
Average shareholder expectation
Revenue Estimate
$20.90 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0660 6.60%
Total Calls200,000 619.42%
Total Puts13,200 Infinity%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %80.08% 0.18%
Total Invested$191.10M 34.87%
Investors Holding160 10.00%

ESG Score

No data

About Simulations Plus Inc.

108 employees

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...